Complexity and challenges in defining myeloid-derived suppressor cells
about
Monitoring of the Immune Dysfunction in Cancer PatientsMyeloid-derived suppressor cells in the tumor microenvironment: expect the unexpectedThe Nature of Myeloid-Derived Suppressor Cells in the Tumor MicroenvironmentTumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophagesImmunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer.CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and FunctionTranscriptional regulation of myeloid-derived suppressor cells.Rapid dissemination of RET-transgene-driven melanoma in the presence of non-obese diabetic alleles: Critical roles of Dectin-1 and Nitric-oxide synthase type 2.Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions.Transformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model.The interplay of epigenetic therapy and immunity in locally recurrent or metastatic estrogen receptor-positive breast cancer: Correlative analysis of ENCORE 301, a randomized, placebo-controlled phase II trial of exemestane with or without entinostaMonocytic myeloid-derived suppressor cells as a potent suppressor of tumor immunity in non-small cell lung cancer.CD33(+) /HLA-DR(neg) and CD33(+) /HLA-DR(+/-) Cells: Rare Populations in the Human Decidua with Characteristics of MDSC.Adoptive T-cell therapy: a need for standard immune monitoring.Myeloid-derived suppressor cells in B cell malignancies.Drafting the proteome landscape of myeloid-derived suppressor cells.Splenectomy suppresses growth and metastasis of hepatocellular carcinoma through decreasing myeloid-derived suppressor cells in vivo.Myeloid-Derived Suppressor Cells in Cancers and Inflammatory Diseases: Angel or Demon?Tumor-Associated Macrophages and Myeloid-Derived Suppressor Cells as Immunosuppressive Mechanism in Ovarian Cancer Patients: Progress and Challenges.Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer.Human Myeloid-derived Suppressor Cells are Associated With Chronic Immune Suppression After Severe Sepsis/Septic Shock.Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study.Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis.Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1.Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy.Inflammatory microenvironment in the initiation and progression of bladder cancer.Myeloid-derived suppressor cells coming of age.Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy.Perspectives of Immune Suppression in the Tumor Microenvironment Promoting Oral Malignancy.Presence of Infected Gr-1CD11bCD11c Monocytic Myeloid Derived Suppressor Cells Subverts T Cell Response and Is Associated With Impaired Dendritic Cell Function in -Infected MiceIssue Highlights-March 2015Immune and genomic signatures in oral (head and neck) cancer
P2860
Q28072712-DECA42BE-F708-48CF-9AAD-C9CBAE5C2AA7Q28084627-57E851B5-D36A-406C-B25B-1115871E26D1Q28388630-9BDE6A6F-E41F-401D-811B-A7417BCEEE0AQ34044797-553FE46B-02D4-447A-8638-773BF2E37F61Q35799185-B78A016B-EEF3-445E-B9B2-F8933AE985B5Q36204706-BACFB4B2-C2D7-4CE8-A778-F07A9EC1EBBAQ36322351-E1B99973-F666-4D08-A2DF-561688E68CDFQ37012718-6337A53F-6299-4068-8E7A-09EA6A405733Q37062216-33DD2928-921F-4798-AB96-8CDBC6BD7DB3Q37109800-8C8DD615-17C2-481A-B8CA-693E0A55D9FEQ37477372-1D6D14C0-614A-4867-9EF3-195715B51FAAQ37581919-1723863A-3DFB-46A9-A27E-1C61327A09FFQ38294011-5D2AF937-ED0F-4AB9-9105-CF2314E8F342Q38525029-6E42B232-F39A-4C80-A3F3-CF119CACFABEQ38578686-155BD2C4-DBB0-4A7B-B9EA-AC5041376AA8Q38592376-BE02D508-CAE4-4BAB-B1AB-B041CA2B93BAQ38740336-EF889654-203F-433D-919C-AB6CE1796A64Q38931895-0F2BE77A-079B-4DFD-99A2-1EE4EA2CBE55Q38958680-134F2F5D-E8F3-4CBA-8CA7-F6874E63F5EBQ39313889-B137998D-D4F1-4452-BF08-CA7F0EC1F19EQ39613201-F2C59748-3B82-4AF2-B77C-FB1157E705C8Q39779016-638EE99C-0E12-40BF-A878-BB4A587CF278Q40148008-02F06673-3F6B-4A7B-9473-F3D159C72D43Q40350208-952EEBC1-89C9-4FCD-A62C-E1DA3569279FQ40526734-68A3EE35-E4F1-440F-B306-5237F98CAEB4Q42644178-3A577321-7ED5-4DD6-A5D7-137E70219AA8Q46779353-82C63072-7AE6-4856-830E-1361FDB28799Q48215791-1A01E986-7CBA-4D3D-84CA-A53D47811D68Q52668399-C0B8928C-D6FD-4E3B-91FD-98C318FD6F1FQ52722792-240D29F4-94C5-4BD7-9E5A-D4D876CCA114Q55511990-2613AF88-B158-43D8-9A7C-D289EE6C1295Q58553806-162ECA53-8AC3-463C-9890-FB4450252686Q58616826-83D5F828-C98B-4FBB-A46A-AD1C8D585477Q58700648-ABA24E07-6221-4CE0-BA0A-BEC816402CB2
P2860
Complexity and challenges in defining myeloid-derived suppressor cells
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Complexity and challenges in defining myeloid-derived suppressor cells
@ast
Complexity and challenges in defining myeloid-derived suppressor cells
@en
type
label
Complexity and challenges in defining myeloid-derived suppressor cells
@ast
Complexity and challenges in defining myeloid-derived suppressor cells
@en
prefLabel
Complexity and challenges in defining myeloid-derived suppressor cells
@ast
Complexity and challenges in defining myeloid-derived suppressor cells
@en
P2093
P2860
P50
P356
P1476
Complexity and challenges in defining myeloid-derived suppressor cells
@en
P2093
Giacomo Desantis
Ilaria Marigo
Vincenzo Bronte
P2860
P356
10.1002/CYTO.B.21206
P577
2014-12-12T00:00:00Z